本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Bolt Biotherapeutics, Inc.

0.3500
+0.01805.42%
盤後0.36000.0100+2.86%19:13 EDT
成交量:3.55萬
成交額:1.22萬
市值:1,341.89萬
市盈率:-0.21
高:0.3600
開:0.3491
低:0.3320
收:0.3320
資料載入中...
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/14

重要事件披露

Form 8-K - Current report
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/29

重要事件披露

8-K - Current report
2023/03/29

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/14

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report